Exchange: NASDAQ·Updated 11:09 AM EDT
TRDA logo

TRDAEntrada Therapeutics Inc

$7.71
$0.01
(0.13%)
Today
EarningsAug 5
Mkt Cap$299.7M
Vol44,993.00

About

Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which provides of a class of medicines that engages in intracellular targets. Its Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. The company was founded by Dehua Pei in 2016 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
152

Frequently Asked Questions

What is Market Cap of Entrada Therapeutics Inc?
What is the 52-week high for Entrada Therapeutics Inc?
What is the 52-week low for Entrada Therapeutics Inc?
What is Entrada Therapeutics Inc stock price today?
What was Entrada Therapeutics Inc stock price yesterday?
What is the PE ratio of Entrada Therapeutics Inc?
What is the Price-to-Book ratio of Entrada Therapeutics Inc?
What is the 50-day moving average of Entrada Therapeutics Inc?
How many employees does Entrada Therapeutics Inc have?

Advertisement|Remove ads.